Pharmacological Blockade of TEAD-YAP Reveals Its Therapeutic Limitation in Cancer Cells

Investigators showed that TEA/TEF-domain transcription factors (TEAD) palmitoylation inhibitor MGH-CP1 and analogs blocked cancer cell “stemness”, organ overgrowth, and tumor initiation in vitro and in vivo.